A preliminary prospective study from Boucek et al. [168] compared the Treg frequency (determined as CD4+CD25+ Tcells) in the blood of SCCHN patients (n = 112) at the time of diagnosis compared to healthy donors. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.